Literature DB >> 29499499

Generation of RAB39B knockout isogenic human embryonic stem cell lines to model RAB39B-mediated Parkinson's disease.

Yujing Gao1, Gabrielle R Wilson1, Kiymet Bozaoglu1, Andrew G Elefanty2, Edouard G Stanley3, Mirella Dottori4, Paul J Lockhart5.   

Abstract

Mutations in RAB39B are a known cause of X-linked early onset Parkinson's disease. Isogenic human embryonic stem cell lines carrying two independent deletions of RAB39B were generated using CRISPR/Cas9 genome editing tool. The deletions were confirmed by PCR and direct sequence analysis in two edited stem cell lines. Both cell lines showed pluripotency and displayed a normal karyotype. Further, they were able to form embryoid bodies in vitro, and express markers indicative of differentiation to the three germ layers.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29499499     DOI: 10.1016/j.scr.2018.02.015

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  2 in total

Review 1.  CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.

Authors:  Fatemeh Safari; Gholamreza Hatam; Abbas Behzad Behbahani; Vahid Rezaei; Mazyar Barekati-Mowahed; Peyman Petramfar; Farzaneh Khademi
Journal:  Cell Mol Neurobiol       Date:  2019-11-26       Impact factor: 5.046

2.  Distribution of Parkinson's disease associated RAB39B in mouse brain tissue.

Authors:  Yujing Gao; Gabrielle R Wilson; Sarah E M Stephenson; Mustapha Oulad-Abdelghani; Nicolas Charlet-Berguerand; Kiymet Bozaoglu; Catriona A McLean; Paul Q Thomas; David I Finkelstein; Paul J Lockhart
Journal:  Mol Brain       Date:  2020-03-30       Impact factor: 4.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.